BSF Enterprise Plc Total Assets
BSF Enterprise Plc total assets. Based on the latest financial reports, BSF Enterprise Plc (BSFA) holds total assets worth GBX3.01 Million GBX (≈ $365.85 USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BSFA market cap overview for the company's overall valuation and market capitalisation.
Total Assets of BSF Enterprise Plc (2019–2025)
Total assets of BSF Enterprise Plc from 2019 to 2025. This chart illustrates how BSF Enterprise Plc's total assets have evolved over time, based on quarterly financial data. See BSF Enterprise Plc stock price for real-time trading data and today's change.
BSF Enterprise Plc - Asset Composition Analysis
BSF Enterprise Plc Total Assets Breakdown (September 2025)
BSF Enterprise Plc total assets breakdown as of September 2025. BSF Enterprise Plc's total assets of GBX3.01 Million consist of 15.6% current assets and 84.4% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 5.0% |
| Accounts Receivable | GBX230.09K | 7.7% |
| Inventory | GBX87.14K | 2.9% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX0.00 | 0.0% |
| Goodwill | GBX2.49 Million | 82.7% |
Asset Composition Trend (2019–2025)
This chart illustrates how BSF Enterprise Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore BSFA net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BSF Enterprise Plc's current assets represent 15.6% of total assets in 2025, a decrease from 100.0% in 2019.
- Cash Position: Cash and equivalents constituted 5.0% of total assets in 2025, down from 100.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 82.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 82.7% of total assets.
BSF Enterprise Plc Competitors by Total Assets
Key competitors of BSF Enterprise Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
CSL LTD SPON.ADR 2
F:CSJA
|
Germany | €38.45 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578
|
China | CN¥8.59 Billion |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278
|
China | CN¥3.21 Billion |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
PHARVARIS N.V. EO -12
F:9EN
|
Germany | €301.45 Million |
|
NANOBIOTIX S.A. SP.ADR
F:5NRA
|
Germany | €67.76 Million |
|
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513
|
China | CN¥3.82 Billion |
BSF Enterprise Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.70 | 2.96 | 14.12 |
| Quick Ratio | 1.38 | 2.74 | 14.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX192.40K | GBX567.40K | GBX423.14K |
BSF Enterprise Plc - Advanced Valuation Insights
This section examines the relationship between BSF Enterprise Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.85 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -14.0% |
| Total Assets | GBX3.01 Million |
| Market Capitalization | $14.84K USD |
Valuation Analysis
Below Book Valuation: The market values BSF Enterprise Plc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: BSF Enterprise Plc's assets decreased by 14.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BSF Enterprise Plc (2019–2025)
The table below shows the annual total assets of BSF Enterprise Plc from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | GBX3.01 Million ≈ $365.85 |
-13.98% |
| 2024-09-30 | GBX3.50 Million ≈ $425.30 |
-33.55% |
| 2023-09-30 | GBX5.26 Million ≈ $640.06 |
+30.46% |
| 2022-09-30 | GBX4.03 Million ≈ $490.63 |
+904.48% |
| 2021-09-30 | GBX401.45K ≈ $48.84 |
-11.85% |
| 2020-09-30 | GBX455.40K ≈ $55.41 |
-17.53% |
| 2019-09-30 | GBX552.20K ≈ $67.19 |
-- |
About BSF Enterprise Plc
BSF Enterprise Plc develops and commercializes cutting-edge tissue-engineered solutions. It offers lab-grown leather, cultivated meat, and corneal repair technologies. The company was incorporated in 2018 and is based in London, United Kingdom.